According to a new report from Intel Market Research, the Europe Graft Versus Host Disease (GvHD) market was valued at USD 345.6 million in 2024 and is projected to reach USD 567.8 million by 2030, growing at a CAGR of 8.6% during the forecast period (2025–2030). This growth is driven by increasing stem cell transplantation rates, advancements in immunosuppressive therapies, and improved...
According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031.
Graft versus Host Disease, a serious complication following stem cell or bone...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek